813 related articles for article (PubMed ID: 17542025)
1. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L
Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025
[TBL] [Abstract][Full Text] [Related]
2. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
[TBL] [Abstract][Full Text] [Related]
3. Five-color flow cytometric analysis of swine lymphocytes for detection of proliferation, apoptosis, viability, and phenotype.
Waters WR; Harkins KR; Wannemuehler MJ
Cytometry; 2002 Jul; 48(3):146-52. PubMed ID: 12116360
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
5. Sequential univariate gating approach to study the effects of erythropoietin in murine bone marrow.
Achuthanandam R; Quinn J; Capocasale RJ; Bugelski PJ; Hrebien L; Kam M
Cytometry A; 2008 Aug; 73(8):702-14. PubMed ID: 18496852
[TBL] [Abstract][Full Text] [Related]
6. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
7. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant hematopoietins on blood-loss anemia in mice.
Jones KB; Anderson DW; Longmore GD
Iowa Orthop J; 2005; 25():129-34. PubMed ID: 16089085
[TBL] [Abstract][Full Text] [Related]
9. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects.
Wang W; Horner DN; Chen WL; Zandstra PW; Audet J
Biotechnol Bioeng; 2008 Apr; 99(5):1261-72. PubMed ID: 17969148
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin inhibits gamma-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line.
Liu YY; She ZJ; Yao MH
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):624-9. PubMed ID: 20132233
[TBL] [Abstract][Full Text] [Related]
11. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation.
Ozawa T; Toba K; Kato K; Minagawa S; Saigawa T; Hanawa H; Makiyama Y; Moriyama M; Honma K; Isoda M; Hasegawa G; Naito M; Takahashi M; Aizawa Y
J Mol Cell Cardiol; 2006 May; 40(5):629-38. PubMed ID: 16603182
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
Rogers CE; Bradley MS; Palsson BO; Koller MR
Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
[TBL] [Abstract][Full Text] [Related]
13. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
[TBL] [Abstract][Full Text] [Related]
14. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
[TBL] [Abstract][Full Text] [Related]
15. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
16. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
Wood PA; Hrushesky WJ; Klevecz R
Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
[TBL] [Abstract][Full Text] [Related]
17. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
Johnson CS; Cook CA; Furmanski P
Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1 drives the motility of the erythroid progenitor cell line, UT-7/Epo, via autocrine motility factor.
Mikami M; Sadahira Y; Haga A; Otsuki T; Wada H; Sugihara T
Exp Hematol; 2005 May; 33(5):531-41. PubMed ID: 15850830
[TBL] [Abstract][Full Text] [Related]
19. Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3.
Aispuru GR; Aguirre MV; Aquino-Esperanza JA; Lettieri CN; Juaristi JA; Brandan NC
Cell Biol Int; 2008 Aug; 32(8):966-78. PubMed ID: 18485751
[TBL] [Abstract][Full Text] [Related]
20. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
Randolph JF; Stokol T; Scarlett JM; MacLeod JN
Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
